Why is Bliss GVS Pharma falling/rising?

As of 09-Jul, Bliss GVS Pharma Ltd's stock price is currently at 155.40, reflecting a decrease of 4.65, or 2.91%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 4.66% during this period. Despite a positive performance over the past month with a return of 12.24%, the stock's year-to-date performance shows a decline of 5.62%. The company has reported negative results for the last three consecutive quarters, with a significant drop in profit before tax and profit after tax, which may be contributing to the current downward trend. Additionally, while the stock has a low debt-to-equity ratio and has generated a 41.53% return over the past year, its operating profit has decreased at an annual rate of -2.54% over the last five years, indicating poor long-term growth prospects.
In the broader market context, the stock has outperformed the benchmark Sensex in the long term, particularly over the last three years, but it has underperformed in the short term, with a weekly return of 0.29% compared to the Sensex's 0.15%. The recent decline in stock price, coupled with rising investor participation, suggests a complex market sentiment where investors may be cautious due to the company's recent financial performance and lack of confidence from domestic mutual funds, which hold no stake in the company. This lack of institutional support could further impact investor sentiment negatively, contributing to the stock's current decline.